AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

INSULIN

14 registrations across 5 African markets— 10 active

Markets with INSULIN

Recent registrations

Brand / ProductMarketHolderStatusExpires
TRESIBA FLEXTOUCH
INJECTABLE; INJECTION
🇿🇼ZimbabweNOVO-NORDISK A/SactiveJun 2031
RYZODEGFLEXTOUCH 100U/ML 5x3ml🇬🇭GhanaexpiredAug 2026
RYZODEGFLEXTOUCH 100U/ML 5x3ml🇬🇭GhanaexpiredAug 2026
RYZODEGFLEXTOUCH 100U/ML 1x3ml🇬🇭GhanaexpiredAug 2026
RYZODEGFLEXTOUCH 100U/ML 1x3ml🇬🇭GhanaexpiredAug 2026
ACTRAPID HM (ge)🇿🇦South AfricaNovo Nordisk (Pty) Ltd û (Rivonia)activeJan 1900
Mixtard 30 Flexpen
Suspension for injection
🇹🇿TanzaniaNovo Nordisk A/Sactive
MIXTRAD FLEXPEN
Suspension for injection
🇹🇿TanzaniaNovo Nordisk A/Sactive
INSULIN🇺🇬UgandaWOCKHARDT LTDactive
INSULIN🇺🇬UgandaWOCKHARDT LTDactive
GENSULIN R
Solution for injection
🇹🇿TanzaniaBIOTON S.Aactive
Jusline R
Suspension for injection
🇹🇿TanzaniaGulf Pharmaceutical Industries-Julpharactive
HUMODAR C25 100R
Suspension for injection
🇹🇿TanzaniaMORAF PHARMACEUTICALS LTDactive
Mixtard
Injection
🇹🇿TanzaniaNovo Nordisk A/Sactive

INSULIN in Africa — Regulatory Overview

INSULIN is registered across 5 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Ghana, Uganda, South Africa and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 14 registrations, 10 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.